Quarterly report pursuant to Section 13 or 15(d)

SHAREHOLDERS' DEFICIT - Additional Information (Details)

v3.24.1.1.u2
SHAREHOLDERS' DEFICIT - Additional Information (Details)
 1 Months Ended 3 Months Ended
Aug. 16, 2023
Mar. 31, 2023
$ / shares
shares
Mar. 31, 2024
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
$ / shares
shares
May 14, 2024
shares
Dec. 31, 2023
$ / shares
shares
Sep. 30, 2022
shares
SHAREHOLDERS' EQUITY (DEFICIT)              
Common stock, shares authorized   9,000,000 9,000,000 9,000,000 250,000,000 9,000,000 180,000,000
Common stock, par value (in dollars per share) | $ / shares   $ 0.001 $ 0.001 $ 0.001   $ 0.001  
Common stock, shares issued     8,326,589     6,720,460  
Common stock, shares outstanding     8,326,589     6,720,460  
Holders of number of shares of common stock present and approved for increase of authorized shares         5,427,462    
Period to submit plan to regain compliance 45 days            
Proceeds from share issuance, net of share issuance costs | $       $ 300,000      
Stock-based compensation (in shares)     268,758        
Reverse stock split ratio   0.05          
Fractional shares issued   0          
Gross proceeds | $       $ 300,000      
Convertible Debt              
SHAREHOLDERS' EQUITY (DEFICIT)              
Common shares issued to settle amounts owed | $     1,337,371        
Debt repaid | $     $ 334,000        
Debt Instrument, Convertible, Settlement Method [Extensible Enumeration]     us-gaap:ShareSettlementMember        
Amended Stock Option Plan              
SHAREHOLDERS' EQUITY (DEFICIT)              
Common stock, shares outstanding     19,555        
Equity Incentive Plan              
SHAREHOLDERS' EQUITY (DEFICIT)              
Common stock, shares outstanding     1,500        
Number of shares authorized     98,500        
Private Placements              
SHAREHOLDERS' EQUITY (DEFICIT)              
Shares issued     50,000        
Gross proceeds | $     $ 300,000        
Shares issue price | $ / shares     $ 6.00